Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6976 to 6990 of 7710 results

  1. Nivolumab in combination for treating hormone-relapsed metastatic prostate cancer before chemotherapy [ID1619]

    Discontinued [GID-TA10490]

    Technology appraisal guidance
    Discontinued

  2. Haemochromatosis

    Discontinued [GID-NG10287]

    NICE guideline
    Discontinued

  3. Acute bowel obstruction

    Discontinued [GID-NG10377]

    NICE guideline
    Discontinued

  4. Endometriosis: diagnosis and management - surgical management - pain management post-surgery

    Discontinued [GID-NG10385]

    NICE guideline
    Discontinued

  5. Breathlessness

    Discontinued [GID-NG10387]

    NICE guideline
    Discontinued

  6. Lower urinary tract symptoms in men, trans and non-binary people with a prostate: assessment and management (update)

    Discontinued [GID-NG10300]

    NICE guideline
    Discontinued

  7. Atopic Dermatitis (Eczema)

    Discontinued [GID-NG10289]

    NICE guideline
    Discontinued

  8. Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]

    In development [GID-TA10391] Expected publication date: TBC

    Technology appraisal guidance
    In development

  9. Surgical site infections: prevention and treatment - Update

    Discontinued [GID-NG10374]

    NICE guideline
    Discontinued

  10. Type 2 diabetes in adults: management - insulin therapy

    Discontinued [GID-NG10375]

    NICE guideline
    Discontinued

  11. Nivolumab for neoadjuvant and adjuvant treatment of localised renal cell carcinoma [ID4047]

    Discontinued [GID-TA10927]

    Technology appraisal guidance
    Discontinued

  12. Pegcetacoplan for amyotrophic lateral sclerosis TS ID 10594

    In development [GID-TA11310] Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Zio Service for detecting cardiac arrhythmias (MIB101)

    This advice has been updated and replaced by NICE medical technologies guidance 52.

    Medtech innovation briefing
    Published
    28 March 2017

  14. PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)

    This advice has been updated and replaced by NICE medical technologies guidance 48.

    Medtech innovation briefing
    Published
    10 November 2015

  15. Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

    NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

    Medtech innovation briefing
    Published
    26 October 2016